vs
AdvanSix Inc.（ASIX）与福尼克斯（PLAB）财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是福尼克斯的1.7倍（$359.9M vs $210.4M），福尼克斯净利率更高（10.9% vs -0.8%，领先11.7%），AdvanSix Inc.同比增速更快（9.4% vs -5.5%），AdvanSix Inc.自由现金流更多（$36.1M vs $25.2M），过去两年AdvanSix Inc.的营收复合增速更高（3.4% vs -3.8%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
福尼克斯是美国半导体光掩模制造商，2009年时位居全球第三大光掩模供应商，同时也是电子束产业倡议组织的成员，专注于为半导体行业提供关键的掩模产品，支撑芯片制造环节的图形转移需求。
ASIX vs PLAB — 直观对比
营收规模更大
ASIX
是对方的1.7倍
$210.4M
营收增速更快
ASIX
高出14.9%
-5.5%
净利率更高
PLAB
高出11.7%
-0.8%
自由现金流更多
ASIX
多$10.9M
$25.2M
两年增速更快
ASIX
近两年复合增速
-3.8%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $210.4M |
| 净利润 | $-2.8M | $22.9M |
| 毛利率 | 7.6% | 33.7% |
| 营业利润率 | -0.7% | 22.9% |
| 净利率 | -0.8% | 10.9% |
| 营收同比 | 9.4% | -5.5% |
| 净利润同比 | -892.9% | -32.4% |
| 每股收益（稀释后） | $-0.11 | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXPLAB
| Q4 25 | $359.9M | — | ||
| Q3 25 | $374.5M | $210.4M | ||
| Q2 25 | $410.0M | $211.0M | ||
| Q1 25 | $377.8M | $212.1M | ||
| Q4 24 | $329.1M | $222.6M | ||
| Q3 24 | $398.2M | $211.0M | ||
| Q2 24 | $453.5M | $217.0M | ||
| Q1 24 | $336.8M | $216.3M |
净利润ASIXPLAB
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.6M | $22.9M | ||
| Q2 25 | $31.4M | $8.9M | ||
| Q1 25 | $23.3M | $42.9M | ||
| Q4 24 | $352.0K | $33.9M | ||
| Q3 24 | $22.3M | $34.4M | ||
| Q2 24 | $38.9M | $36.3M | ||
| Q1 24 | $-17.4M | $26.2M |
毛利率ASIXPLAB
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | 33.7% | ||
| Q2 25 | 14.3% | 36.9% | ||
| Q1 25 | 14.2% | 35.6% | ||
| Q4 24 | 3.4% | 37.0% | ||
| Q3 24 | 14.4% | 35.6% | ||
| Q2 24 | 17.9% | 36.5% | ||
| Q1 24 | 0.9% | 36.6% |
营业利润率ASIXPLAB
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.9% | 22.9% | ||
| Q2 25 | 7.7% | 26.4% | ||
| Q1 25 | 7.7% | 24.6% | ||
| Q4 24 | -3.9% | 25.1% | ||
| Q3 24 | 7.5% | 24.7% | ||
| Q2 24 | 11.5% | 25.8% | ||
| Q1 24 | -7.0% | 26.6% |
净利率ASIXPLAB
| Q4 25 | -0.8% | — | ||
| Q3 25 | -0.7% | 10.9% | ||
| Q2 25 | 7.7% | 4.2% | ||
| Q1 25 | 6.2% | 20.2% | ||
| Q4 24 | 0.1% | 15.2% | ||
| Q3 24 | 5.6% | 16.3% | ||
| Q2 24 | 8.6% | 16.7% | ||
| Q1 24 | -5.2% | 12.1% |
每股收益（稀释后）ASIXPLAB
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.10 | $0.39 | ||
| Q2 25 | $1.15 | $0.15 | ||
| Q1 25 | $0.86 | $0.68 | ||
| Q4 24 | $0.02 | $0.54 | ||
| Q3 24 | $0.82 | $0.55 | ||
| Q2 24 | $1.43 | $0.58 | ||
| Q1 24 | $-0.65 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $575.8M |
| 总债务越低越好 | — | $16.0K |
| 股东权益账面价值 | $815.2M | $1.1B |
| 总资产 | $1.7B | $1.8B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ASIXPLAB
| Q4 25 | $19.8M | — | ||
| Q3 25 | $23.7M | $575.8M | ||
| Q2 25 | $18.4M | $558.4M | ||
| Q1 25 | $8.3M | $642.2M | ||
| Q4 24 | $19.6M | $640.7M | ||
| Q3 24 | $17.3M | $606.4M | ||
| Q2 24 | $12.1M | $559.9M | ||
| Q1 24 | $20.6M | $521.5M |
总债务ASIXPLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $16.0K | ||
| Q2 25 | — | $19.0K | ||
| Q1 25 | — | $21.0K | ||
| Q4 24 | — | $25.0K | ||
| Q3 24 | — | $28.0K | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $2.7M |
股东权益ASIXPLAB
| Q4 25 | $815.2M | — | ||
| Q3 25 | $818.2M | $1.1B | ||
| Q2 25 | $823.7M | $1.1B | ||
| Q1 25 | $794.4M | $1.1B | ||
| Q4 24 | $774.6M | $1.1B | ||
| Q3 24 | $766.4M | $1.1B | ||
| Q2 24 | $746.6M | $1.0B | ||
| Q1 24 | $713.2M | $1.0B |
总资产ASIXPLAB
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $1.8B | ||
| Q2 25 | $1.6B | $1.7B | ||
| Q1 25 | $1.6B | $1.7B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.5B | $1.6B |
负债/权益比ASIXPLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $50.1M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | $25.2M |
| 自由现金流率自由现金流/营收 | 10.0% | 12.0% |
| 资本支出强度资本支出/营收 | 7.7% | 11.8% |
| 现金转化率经营现金流/净利润 | — | 2.19× |
| 过去12个月自由现金流最近4个季度 | $6.4M | $64.5M |
8季度趋势，按日历期对齐
经营现金流ASIXPLAB
| Q4 25 | $63.7M | — | ||
| Q3 25 | $26.6M | $50.1M | ||
| Q2 25 | $21.1M | $31.5M | ||
| Q1 25 | $11.4M | $78.5M | ||
| Q4 24 | $64.2M | $68.4M | ||
| Q3 24 | $57.3M | $75.1M | ||
| Q2 24 | $50.2M | $76.5M | ||
| Q1 24 | $-36.2M | $41.5M |
自由现金流ASIXPLAB
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | $25.2M | ||
| Q2 25 | $-7.2M | $-29.1M | ||
| Q1 25 | $-22.6M | $43.3M | ||
| Q4 24 | $29.8M | $25.2M | ||
| Q3 24 | $26.8M | $50.7M | ||
| Q2 24 | $16.7M | $56.5M | ||
| Q1 24 | $-71.6M | $-1.8M |
自由现金流率ASIXPLAB
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | 12.0% | ||
| Q2 25 | -1.7% | -13.8% | ||
| Q1 25 | -6.0% | 20.4% | ||
| Q4 24 | 9.1% | 11.3% | ||
| Q3 24 | 6.7% | 24.0% | ||
| Q2 24 | 3.7% | 26.0% | ||
| Q1 24 | -21.3% | -0.8% |
资本支出强度ASIXPLAB
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | 11.8% | ||
| Q2 25 | 6.9% | 28.7% | ||
| Q1 25 | 9.0% | 16.6% | ||
| Q4 24 | 10.4% | 19.4% | ||
| Q3 24 | 7.7% | 11.6% | ||
| Q2 24 | 7.4% | 9.2% | ||
| Q1 24 | 10.5% | 20.0% |
现金转化率ASIXPLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 2.19× | ||
| Q2 25 | 0.67× | 3.55× | ||
| Q1 25 | 0.49× | 1.83× | ||
| Q4 24 | 182.29× | 2.02× | ||
| Q3 24 | 2.57× | 2.18× | ||
| Q2 24 | 1.29× | 2.11× | ||
| Q1 24 | — | 1.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
